Excellent Start in Performance: STAR Market's First Q1 Report Released

Securities Times, by Zhang Shuxian

On the evening of April 10, the first quarterly report (Q1 2025) of a STAR Market-listed company was released, marking a robust excellent start in performance. Meanwhile, 14 additional STAR Market companies voluntarily disclosed positive earnings forecasts, with 9 projecting growth and 5 turning losses into profits.

Sustained Growth Momentum Across Multiple Firms

Several companies continued their upward trajectory: Xi'an High Voltage Apparatus Research Institute Co., Ltd., a power equipment testing firm, reported Q1 revenue of RMB 207 million (+12.1% YoY) and net profit of RMB 62.974 million (+12.1% YoY), driven by R&D breakthroughs in traditional power equipment, growth in new energy testing services, and its acquisition of Henan High Voltage Apparatus Research Institute. Suzhou Uigreen Micro & Nano Technologies Co., Ltd. achieved a 112% YoY revenue surge and returned to profitability, attributed to higher sales of high-margin products and expanded market reach. Telink Semiconductor (Shanghai) Co., Ltd. posted RMB 230 million in revenue (+43% YoY) and net profit of about RMB 35 million (+894% YoY), benefiting from rising digitalization/intelligence penetration in downstream sectors, increased client shipments, and a higher proportion of sales from high-margin products and economies of scale. Zhangjiagang Guangda Special Material Co., Ltd. reported RMB 1.12 billion in revenue, with net profit soaring 1,504.79% YoY, fueled by strong downstream demand, the ramp-up of its wind turbine gearbox components project, and improved efficiency from IPO-funded projects. Biotech firms like Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. and Chengdu Sheng Nuo Biotec Co., Ltd. saw peptide API sales double, lifting net profits over 100% YoY amid industry tailwinds.

Operational, R&D, and Shareholder Return Highlights

Driven by technological innovation and industrial upgrading, STAR Market companies maintained strong R&D momentum and pragmatic business strategies in the first quarter. Shanghai United Imaging Healthcare Co., Ltd. disclosed the status of medical device registration certificates in domestic and major overseas markets for 2025, including seven achievements in fields such as vascular angiography and magnetic resonance imaging. The products have achieved global registration coverage in over 80 countries and regions, with a cumulative total of more than 140 approved listings. PERIC Special Gases Co., Ltd. reported both production and sales growth in Q1 2025, with new orders for trifluoromethanesulfonic acid products up 142.42% YoY.

STAR Market companies have also consolidated their investment value, with many releasing repurchase and share increase plans. Since 2025, 33 new share buyback plans have been announced, with maximum intended repurchases of RMB 3.215 billion; 9 new share increase plans have been released, with a planned upper limit of RMB 696 million. Since April, companies such as Autel Intelligent Technology Corp., Ltd. and AVIC (Chengdu) UAS Co., Ltd. have announced their latest share repurchase plans, intending to buy back company shares with amounts ranging from RMB 100 million to RMB 200 million. In the integrated circuit and new energy sectors, Solax Power Network Technology (Zhejiang) Co., Ltd. and Crystal Growth & Energy Equipment Inc.'s actual controllers have respectively increased their holdings in the companies by RMB 20 million to RMB 30 million and RMB 10 million to RMB 20 million, thereby achieving a long-term binding of the "key minority" with the value of the enterprises.

The above information is provided for reference purposes only and does not constitute investment advice.